Global Biodefense Market Overview  

• The Global Biodefense Market Size was worth around USD 15.98 Billion in 2023 and is predicted to grow to around USD 25.94 Billion by 2033 with a compound annual growth rate (CAGR) of 4.96% between 2023 and 2033.
• The sector devoted to the creation, manufacturing, and use of technological, medical, and strategic solutions meant to safeguard civilians and military personnel against biological threats is known as the biodefense market. 
• Growing government attempts to improve preparation against Chemical, Biological, Radiological, and Nuclear (CBRN) threats are one of the main reasons driving the growth of the biodefense market.
• The growing significance of biodefense and the increasing threat of dangerous biological agents that create emergencies are also driving the biodefense market. 

Major vendors in the Global Biodefense Market

XOMA corporation, Altimmune Inc., Emergent Biosolutions Inc., Dynavax Technologies Corporation, SIGA Technologies; Elusys Therapeutics Inc., Ichor Medical Systems, Dynport Vaccine Company, and Others.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Decision Advisor has segmented the Biodefense market based on the below-mentioned segments:

Global Biodefense Market, By Product

• Anthrax
• Smallpox
• Botulism
• Radiation/Nuclear
• Others

Global Biodefense Market, By Application

• Military
• Civilian

Global Biodefense Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa